Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from Russell 2000 Growth Index
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.595 USD | +3.21% | +11.54% | +8.50% |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.50% | 83.26M | |
-1.93% | 104B | |
+6.84% | 97.47B | |
+5.71% | 22.25B | |
-12.67% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.63% | 16.36B | |
+6.94% | 14.39B | |
+36.13% | 12.37B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Spero Therapeutics, Inc.(NasdaqGS: SPRO) dropped from Russell 2000 Growth Index